Two of the candidates are Israeli: Chen Lichtenstein and Ran Maidan.
Erez Vigodman will apparently be appointed CEO of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) later this month, and Makhteshim Agan Industries Ltd. will appoint someone to succeed him as CEO of the company. Makhteshim is owned by China National Chemical Corporation (ChemChina), with a 60% stake, and IDB Holding Corp. Ltd. (TASE:IDBH) unit Koor Industries Ltd. (TASE:KOR).
Two of the four candidates to succeed Vigodman are Israeli: Makhteshim deputy CEO Chen Lichtenstein, and Makhteshim Asia-Pacific, Africa and the Middle East CEO Ran Maidan.
One of the foreign candidates is Makhteshim SVP and head of global products and marketing Ignacio Dominguez, who was appointed in 2012 and relocated to Tel Aviv.
There is reportedly a preference to appoint an Israeli CEO, giving Lichtenstein and Maidan an advantage over the non-Israeli candidates.
Published by Globes [online], Israel business news - www.globes-online.com - on January 7, 2014
© Copyright of Globes Publisher Itonut (1983) Ltd. 2014